Avery Dennison launches AD Minidose U9XM with high memory capability

Avery Dennison launches AD Minidose U9XM with high memory capability to help ensure authenticity and traceability of smaller medical items

Tiny inlays and tags for pharmaceutical and healthcare applications.


MENTOR, Ohio — August 27, 2024 — Avery Dennison has announced the launch of AD Minidose U9XM UHF RFID high memory inlays and tags for the unique identification of small pharmaceutical and healthcare items such as syringes, vials and an array of packaging formats.

Main applications include source tagging, end-to-end traceability and product authentication. AD Minidose U9XM is approved for use in healthcare applications by Auburn University’s RFID Lab. It is one of the smallest inlays available and complies with ARC Category S for pharmaceutical and healthcare applications. 

The new products’ higher memory enables converters, system integrators, healthcare providers, pharmaceutical and medical device OEMs to store additional product information such as expiry date and batch/lot on the item. This provides reliable access at any point in the supply chain without constant cloud lookups, thereby ensuring efficient and dependable tracking. The data available can help to verify product authenticity and reduce the risk of counterfeit goods infiltrating the supply chain. The provision of accessible and accurate product information supports efforts to increase patient safety and care quality.

The NXP U9XM chip offers a self adjust feature to maximize product performance. It provides high read reliability and enhanced performance, even when small tagged items are densely packed in close proximity. AD Minidose U9XM is also available in several different memory sizes from 96 to 496 bit EPC memory to offer flexibility in encoding, read speed, security, cost, standard certification and interoperability.

Mathieu De Backer, vice president innovation & sustainability, Avery Dennison Smartrac, says: “We continue to see a growing demand for small, subtle inlays and tags with high memory, particularly for pharmaceutical and healthcare applications. Combining this provision with long range readability makes the AD Minidose U9XM ideally suited to environments where product authentication and traceability are essential.”

For more information on Avery Dennison’s inlays and tags, click here.

 

Media contact

Jack Gibson
Global PR Manager
jack.gibson@eu.averydennison.com


About Avery Dennison
Avery Dennison Corporation (NYSE: AVY) is a global materials science and digital identification solutions company that provides a wide range of branding and information solutions that optimize labor and supply chain efficiency, reduce waste, advance sustainability, circularity and transparency, and better connect brands and consumers. Our products and solutions include labeling and functional materials, radio frequency identification (RFID) inlays and tags, software applications that connect the physical and digital, and a variety of products and solutions that enhance branded packaging and carry or display information that improves the customer experience. Serving an array of industries worldwide — including home and personal care, apparel, general retail, e-commerce, logistics, food and grocery, pharmaceuticals and automotive — we employ approximately 35,000 employees in more than 50 countries. Our reported sales in 2023 were $8.4 billion. Learn more at www.averydennison.com.

© 2024 Avery Dennison Corporation, All Rights Reserved.

Various trademarks and trade names are used herein and are the property of their respective owners.